Related Experiment Video
Updated: May 2, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
MicroRNAs in gastric cancer metastasis
Zhaoqi Shi1, Qingxia Wei2, Junjun She1
1Department of General Surgery, 1st Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, 710061, Shaan'xi Province, China.
Abstract:
Gastric cancer (GC) is common worldwide and has a high rate of metastasis. The underlying molecular mechanism of metastasis are not entirely clear. MicroRNAs (miRNAs) are small, non-coding RNA molecules that regulate gene expression post-transcriptionally and are reported to be involved in multiple steps of tumor metastasis. Clarifying their roles in GC metastasis will improve understanding of this disease. Here, we review the involvement of miRNAs in multiple steps of GC metastasis, including epithelial-mesenchymal transitions, anoikis, angiogenesis, invasion, and migration. The clinical application of miRNAs as prognostic biomarkers in GC is also discussed.
Insights
This review clarifies the role of microRNAs (miRNAs) in gastric cancer (GC) metastasis, highlighting their involvement in key steps like epithelial-mesenchymal transitions and invasion. Understanding these molecular mechanisms can improve GC prognosis and treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Gastric cancer (GC) is a prevalent malignancy with a high propensity for metastasis.
- The molecular underpinnings of GC metastasis remain incompletely understood.
- MicroRNAs (miRNAs) are key regulators of gene expression implicated in tumor progression.
Purpose of the Study:
- To review the multifaceted roles of miRNAs in various stages of gastric cancer metastasis.
- To elucidate the involvement of miRNAs in epithelial-mesenchymal transitions, anoikis, angiogenesis, invasion, and migration in GC.
- To discuss the potential of miRNAs as prognostic biomarkers for gastric cancer.
Main Methods:
- Comprehensive literature review of studies investigating miRNA involvement in GC metastasis.
- Analysis of miRNA-mediated regulatory networks in key metastatic processes.
- Synthesis of current evidence on clinical applications of miRNAs in GC.
Main Results:
- miRNAs significantly influence multiple steps of GC metastasis, including EMT, anoikis, angiogenesis, invasion, and migration.
- Specific miRNAs have been identified as either promoters or suppressors of GC metastasis.
- miRNAs demonstrate potential as reliable prognostic biomarkers for GC patients.
Conclusions:
- MicroRNAs play critical roles in the complex process of gastric cancer metastasis.
- Targeting specific miRNAs may offer novel therapeutic strategies for GC.
- Further research into miRNA functions and clinical utility is warranted for improved GC management.
Related Concept Videos
MicroRNAs
MicroRNAs
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

